Cover Image
市場調查報告書

肺移植:全球臨床實驗檢討

Lung Transplantation Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318342
出版日期 內容資訊 英文 73 Pages
訂單完成後即時交付
價格
Back to Top
肺移植:全球臨床實驗檢討 Lung Transplantation Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 73 Pages
簡介

本報告提供肺移植相關相關的臨床研究最新趨勢分析,提供疾病·治療方法概要,及主要已開發國家·新興國家的臨床實驗狀況,各地區、Phase、階段的進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,加上有潛力的藥劑比較等資訊,為您概述為以下內容。

目錄

  • 簡介
    • 肺移植
    • 本報告概要
  • 各地區的臨床實驗情形
    • 各國臨床實驗數量和平均實驗人數
      • 亞太地區主要國家的臨床實驗數量
      • 歐洲主要5個國家的臨床實驗數量
      • 北美主要國家的臨床實驗數量
      • 中東·非洲主要國家的臨床實驗數量
  • G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上肺移植所佔的比例
  • G7各國臨床實驗數量:Phase別
  • G7各國臨床實驗數量:各進展狀況
  • E7各國臨床實驗數量:免疫疾病治療藥臨床實驗上肺移植所佔的比例
  • Phase別臨床實驗數量
    • 進行中的臨床實驗:不同階段
  • 各進展狀況臨床實驗數量
  • 臨床實驗的目標的成就情形
  • 未完成的臨床實驗數量:過敏症的情況
  • 一定期間所採用的實驗對像
  • 贊助商類別的臨床實驗數量
  • 有潛力的贊助商
    • 肺移植的治療藥臨床實驗的主要參與企業
  • 有潛力的藥劑
  • 臨床實驗簡介
    • 主要企業臨床實驗概要
      • Novartis AG
      • Astellas Pharma Inc.
      • Pfizer Inc.
      • Ikaria Inc.
      • APT Pharmaceuticals, Inc. (Inactive)
      • GlaxoSmithKline plc
      • Fresenius SE & Co. KGaA
      • F. Hoffmann-La Roche Ltd.
      • Dompe Farmaceutici S.p.A.
      • Alnylam Pharmaceuticals, Inc.
    • 主要研究機關/政府臨床實驗概要
      • Hannover Medical School
      • University of Pittsburgh
      • University of Chicago
      • Katholieke Universiteit Leuven
      • University Health Network
      • The National Institute of Allergy and Infectious Diseases
      • University of California, San Francisco
      • Rabin Medical Center
      • National Heart, Lung, and Blood Institute
      • Nantes University Hospital
  • 5個有代表性的臨床實驗簡介
  • 附錄

圖表一覽

目錄
Product Code: GDHC2391CTIDB

GlobalData's clinical trial report, "Lung Transplantation Global Clinical Trials Review, H2, 2014" provides data on the Lung Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lung Transplantation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lung Transplantation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Lung Transplantation
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Lung Transplantation to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Lung Transplantation to Immunology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Lung Transplantation
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Lung Transplantation Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Ikaria Inc.
      • Clinical Trial Overview of Ikaria Inc.
      • APT Pharmaceuticals, Inc. (Inactive)
      • Clinical Trial Overview of APT Pharmaceuticals, Inc. (Inactive)
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Fresenius SE & Co. KGaA
      • Clinical Trial Overview of Fresenius SE & Co. KGaA
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Dompe Farmaceutici S.p.A.
      • Clinical Trial Overview of Dompe Farmaceutici S.p.A.
      • Alnylam Pharmaceuticals, Inc.
      • Clinical Trial Overview of Alnylam Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Hannover Medical School
      • Clinical Trial Overview of Hannover Medical School
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • University of Chicago
      • Clinical Trial Overview of University of Chicago
      • Katholieke Universiteit Leuven
      • Clinical Trial Overview of Katholieke Universiteit Leuven
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Rabin Medical Center
      • Clinical Trial Overview of Rabin Medical Center
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Nantes University Hospital
      • Clinical Trial Overview of Nantes University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Lung Transplantation Therapeutics, Global, Clinical Trials by Region, 2014*
  • Lung Transplantation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Lung Transplantation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Lung Transplantation to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Lung Transplantation Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Lung Transplantation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Lung Transplantation to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Lung Transplantation Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Lung Transplantation Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Lung Transplantation Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Lung Transplantation Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Lung Transplantation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Inc., 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by APT Pharmaceuticals, Inc. (Inactive), 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Fresenius SE & Co. KGaA, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Dompe Farmaceutici S.p.A., 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Hannover Medical School, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Katholieke Universiteit Leuven, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Lung Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Nantes University Hospital, 2014*

List of Figures

  • Lung Transplantation Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Lung Transplantation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Lung Transplantation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Lung Transplantation Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Lung Transplantation to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Lung Transplantation Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Lung Transplantation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Lung Transplantation to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Lung Transplantation Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Lung Transplantation Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Lung Transplantation Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Lung Transplantation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Lung Transplantation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top